Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators.
about
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSALysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfacesConservative therapy for the management of cardiac implantable electronic device infectionNew perspectives of infections in cardiovascular diseaseCardiac device-related endocarditis: Epidemiology, pathogenesis, diagnosis and treatment - a review.Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients.Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB)Permanent pacemakers and implantable defibrillators: considerations for intensivists.Predictors of mortality in Staphylococcus aureus BacteremiaAn Automated Surveillance Strategy to Identify Infectious Complications After Cardiac Implantable Electronic Device Procedures.Biomarker-based diagnosis of pacemaker and implantable cardioverter defibrillator pocket infections: A prospective, multicentre, case-control evaluation.Management of Cardiac Implantable Electronic Device InfectionTreatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.The oral cavity is not a primary source for implantable pacemaker or cardioverter defibrillator infections.Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.Infections of electrophysiologic cardiac devices.Management of methicillin-resistant Staphylococcus aureus bacteremia.Contemporary management of cardiovascular implantable electronic device infections.From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems.Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination.Appropriate use of echocardiography in managing Staphylococcus aureus bacteremia.Long-term outcomes of cardiovascular implantable electronic devices in patients with Staphylococcus aureus bacteremia.Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population.Contemporary pacemaker and ICD lead management: techniques for lead extraction.Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality.Echocardiography in patients with complications related to pacemakers and cardiac defibrillators.Staphylococcus aureus bacteremia: targeting the source.Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British HeRisk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.Strategies to prevent infections associated with cardiovascular implantable electronic devices.Subcutaneous defibrillators for dialysis patients.Pacemaker endocarditis during 18 years in Göteborg.The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort.Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects.Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis.
P2860
Q22305769-AE940255-3F47-4F05-B968-D960E696A3D8Q24650674-38E2694D-4693-4D2B-859D-B6270EE6139FQ28073827-C76A7231-7CBF-4928-9D39-C991AE96FF4EQ33587960-F710C256-2546-4A56-8C9B-5A3BF574700CQ33989431-408A998D-63C6-4DE8-BF02-40B111C55AD0Q34004568-88C21E24-1A2E-430A-B82A-78A1D25E18FFQ34157657-FC61973B-0C55-44D7-8C40-511837D7EEBBQ34463444-3F0B2245-6AF6-49E9-844C-A41E0628F6C7Q34478074-083282AA-87FE-4804-9EE1-1B81906CA3B8Q34793209-90C97930-F15D-4794-A2DB-BA9178CAB6A6Q35052124-2E02CD99-223A-4E04-8009-30D7255D7F25Q35102274-67AD17F0-ABE3-449E-ACAC-E5F4F83ECB98Q35857270-84D3FD95-7DEF-4E44-B6AD-1C4A5C0BD81FQ35940556-E46FEC74-EF38-4731-8321-0624FBE5496CQ36164683-113B59BC-0547-42A3-B7F3-8DD1DAFC2684Q36298525-4ED9D68F-0AE4-4F5F-98B0-32FEF9B81DBAQ36458826-10D91BF3-3730-412F-B43B-954AF7E3494CQ36758570-3CD55CA4-9A39-4A1D-9A02-B99BE7F35202Q36805325-A50E56B2-6D52-417E-B559-A3EA689F9309Q36903680-DBE10A33-074C-4CF1-9639-5DB3DA23F444Q37106465-9B826281-6EFA-4587-955E-8C5AD49582D8Q37156709-40BAFE34-69EC-4106-940D-506B84CA6E9EQ37768419-5F4E5AB1-5354-4103-B156-4472D3B92454Q37850450-D71342B9-15CD-425A-8573-D4B2354842E2Q37986891-8A1C16E1-E419-42C6-9F0C-07A6A3D20C59Q38003495-B9CCC21D-C667-4C24-B592-7D62199233F5Q38017204-58411961-CC04-4331-AB35-340CA00E7C66Q38017278-48532427-396B-4D78-9E80-0F6A67925E7BQ38036332-ECC73800-08E3-4B45-AE58-74BC1FFFFD67Q38101966-0B7A1FDC-68C5-4794-B3AA-5AB88246D295Q38171531-AFE1724B-32DE-437F-B19D-1786AE3D736AQ38258108-423EABAA-A442-4010-BA12-E62566205412Q38263821-ACCA6D85-4503-4C79-AE8D-5A870C423D9DQ38450566-4A6FB5CA-A5E3-485E-8510-C04DFE4527F1Q39257002-D252AE24-84DE-4936-9B41-4FDDB6745102Q39393728-1169B764-0C39-4FA4-B5F3-D8C3C61E55B8Q39694874-FB5C15D7-3A55-41B4-834F-F55E0954502FQ40075208-2D449943-9635-478C-A3DC-86945ACD495AQ40274849-A106C9FA-8316-4121-B527-5E58E18D86FDQ40338337-35AEA2CD-2841-42CD-AEBC-C0E5C50BA2C4
P2860
Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Staphylococcus aureus bacterem ...... e cardioverter-defibrillators.
@en
Staphylococcus aureus bacterem ...... e cardioverter-defibrillators.
@nl
type
label
Staphylococcus aureus bacterem ...... e cardioverter-defibrillators.
@en
Staphylococcus aureus bacterem ...... e cardioverter-defibrillators.
@nl
prefLabel
Staphylococcus aureus bacterem ...... e cardioverter-defibrillators.
@en
Staphylococcus aureus bacterem ...... e cardioverter-defibrillators.
@nl
P2093
P356
P1433
P1476
Staphylococcus aureus bacterem ...... e cardioverter-defibrillators.
@en
P2093
Fowler VG Jr
Greenfield RA
Peterson GE
Sorrentino RA
P304
P356
10.1161/HC3401.095097
P407
P577
2001-08-01T00:00:00Z